Dawnrays Pharmaceutical Holdings Ltd. Financial Overview
Dawnrays Pharmaceutical Holdings Ltd.'s market cap is currently HK$1.88B. The company's EPS TTM is HK$0.075; its P/E ratio is 9.87; and it has a dividend yield of 5.21%. Dawnrays Pharmaceutical Holdings Ltd. is scheduled to report earnings on August 22, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
